Celldex Therapeutics (CLDX) Non-Current Assets (2010 - 2026)
Celldex Therapeutics (CLDX) posted Non-Current Assets of $57.42 million for Q2 2026, up 30.5% from $44 million a year earlier and up 10.4% from the prior quarter.
Powered by 
Analysis
Celldex Therapeutics (CLDX) Non-Current Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Celldex Therapeutics' Non-Current Assets came in at $48.32 million, up 6.9% from FY2024.
- Annual Non-Current Assets shows a five-year compound annual growth rate of 4.9% (FY2020 to FY2025).
- In prior years, Celldex Therapeutics' Non-Current Assets was $45.18 million in FY2024 (+33.1%), $33.93 million in FY2023 (-3.2%), $35.04 million in FY2022 (+3.6%) and $33.82 million in FY2021 (-11.0%).
- The Q2 2026 figure stands as the highest quarterly Non-Current Assets since Q2 2019.
- On a year-over-year basis, Non-Current Assets has increased in each of the last three quarters, with growth averaging 22.5% over the last eight quarters.
- The strongest year-over-year quarter for Non-Current Assets in the past five years was Q1 2025, with growth of 36.4%; the weakest was Q3 2021, with a decline of 36.3%.
- According to Business Quant data, Non-Current Assets for the three prior quarters was $52.03 million (Q1 2026), $48.32 million (Q4 2025) and $44.1 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 14.88 Bn |
| 10 | Celldex Therapeutics | 2.47 Bn | 2.47 Bn | - | 57.42 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 57.42 Mn |
| Mar 31, 2026 | 52.03 Mn |
| Dec 31, 2025 | 48.32 Mn |
| Sep 30, 2025 | 44.10 Mn |
| Jun 30, 2025 | 44.00 Mn |
| Mar 31, 2025 | 45.71 Mn |
| Dec 31, 2024 | 45.18 Mn |
| Sep 30, 2024 | 44.34 Mn |
| Jun 30, 2024 | 33.61 Mn |
| Mar 31, 2024 | 33.52 Mn |
| Dec 31, 2023 | 33.93 Mn |
| Sep 30, 2023 | 34.32 Mn |
| Jun 30, 2023 | 34.49 Mn |
| Mar 31, 2023 | 34.92 Mn |
| Dec 31, 2022 | 35.04 Mn |
| Sep 30, 2022 | 34.63 Mn |
| Jun 30, 2022 | 34.98 Mn |
| Mar 31, 2022 | 33.34 Mn |
| Dec 31, 2021 | 33.82 Mn |
| Sep 30, 2021 | 33.65 Mn |
API Access
Celldex Therapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=CLDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "CLDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=CLDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();